CompletedNot Applicable

Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients

Indonesia66 participantsStarted 2025-05-06

Plain-language summary

The goal of this clinical trial is to learn if guided imagery therapy using mobile application in Indonesian language can improve sleep quality and lower fasting blood glucose levels in diabetics patients who have problems with their sleep. The main questions it aims to answer are: * Can the app-based guided imagery therapy help improve sleep quality in diabetic patients who have trouble sleeping? * Can the app-based guided imagery therapy help lowering fasting blood glucose in diabetic patients who have trouble sleeping? Researchers will compare app-based guided imagery therapy to education about how to sleep well, to see if the app works to improve sleep quality and lower blood glucose. Participants will: * Receive education about how to sleep well * Use the app 3 times a week for 4 weeks (only for group who receive the app) * Visit the clinic after 4 weeks for tests

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients at Endocrinology or Psychosomatic Clinic, Cipto Mangunkusumo Hospital * Already diagnosed with Diabetes Mellitus * HbA1c less than 12% * Insomnia Severity Index more than 8 * Lives in Jakarta, Bogor, Depok, Tangerang, or Bekasi * Able to understand the Indonesian language well Exclusion Criteria: * History of amputation or routine hemodialysis * No device available to connect with the application * Inability to independently access or use the application * Inability to perform self-monitoring of blood glucose at home * Hearing impairment * Cognitive impairment or intellectual limitations

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Insomnia Severity Index

Timeframe: 4 weeks

Fasting Plasma Glucose

Timeframe: 4 weeks

Trial details

NCT IDNCT07141940

SponsorDr Cipto Mangunkusumo General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-19

View on ClinicalTrials.gov More Diabetes (Insulin-requiring, Type 1 or Type 2) trials